News | March 16, 2022
Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Company expects strong organic growth in sales, EBITDA in 2022
Serina has over 17 years of experience in the biopharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
